Loading...

PE anti-mouse/human CD44 Antibody

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7_PE_071608.jpg
C57BL/6 mouse splenocytes stained with IM7 PE
  • IM7_PE_071608.jpg
    C57BL/6 mouse splenocytes stained with IM7 PE
  • IM7_PE_human
    Human peripheral blood lymphocytes stained with IM7 PE
Compare all formats See PE spectral data
Cat # Size Price Save
103023 25 tests ¥9,680
103007 50 µg ¥9,970
103024 100 tests ¥25,740
103008 200 µg ¥25,990
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
µg sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. For µg sizes, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References

(PubMed link indicates BioLegend citation)
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  2. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  3. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  4. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  5. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  6. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  7. Hu X, et al. 2022. EBioMedicine. 86:104333. PubMed
  8. Gilazieva Z, et al. 2022. Curr Issues Mol Biol. 44:5363. PubMed
  9. Dölz M, et al. 2022. iScience. 25:105372. PubMed
  10. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  11. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  12. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  13. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  14. Zhu H, et al. 2022. Cell Transplant. 31:9636897221106996. PubMed
  15. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  16. Scanlon VM, et al. 2022. Sci Rep. 12:16218. PubMed
  17. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  18. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  19. Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed
  20. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  21. Fukuzaki Y, et al. 2023. iScience. 26:106340. PubMed
  22. Tada T, et al. 2023. JCI Insight. 8:. PubMed
  23. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  24. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  25. A R, et al. 2023. Front Oncol. 13:1147668. PubMed
  26. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  27. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  28. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  29. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  30. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  31. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  32. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  33. Shi Y, et al. 2020. Med Sci Monit. 26:e923328. PubMed
  34. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  35. Hammer A, et al. 2017. J Neuroinflammation. 10.1186/s12974-017-0954-y. PubMed
  36. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  37. Yang C, et al. 2022. Cancers (Basel). 14:. PubMed
  38. MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
  39. Saenz F, et al. 2014. PLoS One. 9:97666. PubMed
  40. Shapiro MR, et al. 2020. Front Immunol. 1.972222222. PubMed
  41. Wang D, et al. 2018. Immunity. 48:659. PubMed
  42. Volpedo G, et al. 2022. NPJ Vaccines. 7:32. PubMed
  43. Byun JK, et al. 2020. Molecular Cell. 80(4):592-606.e8. PubMed
  44. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  45. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  46. Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
  47. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  48. Zhang Q, et al. 2021. Nat Commun. 12:4592. PubMed
  49. Sung SE, et al. 2021. Vet Sci. 8:. PubMed
  50. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  51. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  52. Davila S, et al. 2014. J Immunol. 192:4284. PubMed
  53. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  54. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  55. Trial J, et al. 2017. Basic Research in Cardiology. 10.1007/s00395-017-0623-4. PubMed
  56. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  57. Shao B, et al. 2019. J Immunol. 10.4049/jimmunol.1900680. PubMed
  58. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  59. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  60. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  61. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  62. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  63. Zhuang Z, et al. 2021. J Exp Med. 218:00:00. PubMed
  64. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  65. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  66. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  67. Sandborn WJ, et al. 2021. Gastroenterology. 161:1853. PubMed
  68. Shao W, et al. 2010. Transplant Proc. 42:2777. PubMed
  69. Tyne A, et al. 2013. Vaccine. 31:4322. PubMed
  70. Chulpanova DS, et al. 2020. Bioengineering (Basel). 7:00. PubMed
  71. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  72. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  73. Du L et al. 2019. Cell metabolism. 29(6):1363-1375 . PubMed
  74. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  75. Li P, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.24. PubMed
  76. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  77. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
  78. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  79. Hammer A, et al. 2016. Proc Natl Acad Sci U S A. 113(49):14109-14114. PubMed
  80. Kong T, et al. 2020. Cancer Res. 80:444. PubMed
  81. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  82. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  83. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  84. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  85. Chen Y, et al. 2010. Mol Cancer Ther. 2.374305556. PubMed
  86. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  87. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  88. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  89. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  90. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  91. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  92. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  93. Fu X, et al. 2020. Aging (Albany NY). 12:15656. PubMed
  94. Blacking T, et al. 2011. Vet Immunol Immunopathol. 141:46. PubMed
  95. Sentman A 2011. Blood. 117:6571. PubMed
  96. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  97. Li P, et al. 2018. J Cell Mol Med. 22:3423. PubMed
  98. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  99. Zhang Z, et al. 2019. Cell Death Dis. 10:530. PubMed
  100. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  101. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  102. Tsuchihashi K, et al. 2022. Biochem Biophys Rep. 30:101246. PubMed
  103. Sottnik JL, et al. 2021. Cancer Res. 81:2833. PubMed
  104. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  105. Bian X, et al. 2021. Clin Transl Med. 11:e352. PubMed
  106. Biram A, et al. 2020. Bio Protoc. e3562:10. PubMed
  107. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  108. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  109. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  110. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  111. Nair S, et al. 2021. JCI Insight. 6:. PubMed
  112. Ngamsri KC, et al. 2022. Cells. 11:. PubMed
  113. Yip HYK, et al. 2018. PLoS One. 3. PubMed
  114. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  115. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  116. Ge C, et al. 2020. Cell Reports. 29(13):4236-4244.e3.. PubMed
  117. Melhem H, et al. 2022. Mucosal Immunol. 15:443. PubMed
  118. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  119. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  120. Wang S, et al. 2021. Parasite. 28:13. PubMed
  121. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  122. Xu Y, et al. 2020. Stem Cells Int. 8894449:2020. PubMed
  123. Yeung F, et al. 2020. Cell Host & Microbe. 27(5):809-822. PubMed
  124. Yue X, et al. 2021. EMBO Rep. 22:e52716. PubMed
  125. Herbst SA, et al. 2021. iScience. 24:103062. PubMed
  126. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  127. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  128. Fiume G, et al. 2015. Sci Rep. 5: 13864. PubMed
  129. M H, et al. 2016. Open Bio. 6: 150208. PubMed
  130. M H, et al. 2016. Cell Transplant. 25: 811-27. PubMed
  131. Yermanos A, et al. 2020. Front Immunol. 1.143055556. PubMed
  132. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  133. Pardo E, et al. 2017. PLoS One. 12(6):e0177472. PubMed
  134. Hammer A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01922. PubMed
  135. Morley S, et al. 2008. J Immunol. 181:4696. PubMed
  136. Di Lorenzo A, et al. 2022. Oncoimmunology. 11:2086752. PubMed
  137. Hu J, et al. 2022. J Immunother Cancer. 10:. PubMed
  138. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  139. Girón-Pérez DA, et al. 2020. J Cell Sci. 133:00:00. PubMed
  140. MaruYama T, et al. 2015. J Leukoc Biol. 98: 385-393. PubMed
  141. Lee Y, et al. 2012. Nat Immunol. 13:991. PubMed
  142. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  143. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  144. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  145. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  146. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  147. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  148. Korin B, et al. 2020. Sleep. :43. PubMed
  149. Lu H, et al. 2019. EBioMedicine. 40:276. PubMed
  150. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  151. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  152. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  153. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  154. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  155. Kaji T, et al. 2016. Int Immunol. 28: 267 - 282. PubMed
  156. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  157. Seo MS, et al. 2021. Vet Sci. 8:. PubMed
  158. Hung G, et al. 2022. NPJ Aging. 8:10. PubMed
  159. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  160. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  161. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  162. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  163. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  164. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  165. Pan Y, et al. 2021. NPJ Vaccines. 6:1. PubMed
  166. Velletri T, et al. 2020. Cell Death Differ. . PubMed
  167. Olguín J, et al. 2015. Microbes Infect. 17: 586-595. PubMed
  168. Bonaccorsi-Riani E, et al. 2015. PLoS One. 10: 0136106. PubMed
  169. Upasani V, et al. 2019. Front Immunol. 2.152777778. PubMed
RRID
AB_493686 (BioLegend Cat. No. 103023)
AB_312958 (BioLegend Cat. No. 103007)
AB_493687 (BioLegend Cat. No. 103024)
AB_312959 (BioLegend Cat. No. 103008)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD44
Specificity Alt (DOES NOT SHOW ON TDS):
CD44
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD44 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD44 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD44 IM7 FC
Biotin anti-mouse/human CD44 IM7 FC,ICC,IHC-P
FITC anti-mouse/human CD44 IM7 FC,ICC,IHC-P
PE/Cyanine5 anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 IM7 FC,IHC-F,CyTOF®,ELISA,ICC,IHC-P,IP,CMCD,Stim
Brilliant Violet 605™ anti-mouse/human CD44 IM7 FC
PE anti-mouse/human CD44 IM7 FC
Alexa Fluor® 488 anti-mouse/human CD44 IM7 FC,ICC,IHC-P,SB
Alexa Fluor® 647 anti-mouse/human CD44 IM7 FC,ICC,SB
Pacific Blue™ anti-mouse/human CD44 IM7 FC
Alexa Fluor® 700 anti-mouse/human CD44 IM7 FC,SB
PE/Cyanine7 anti-mouse/human CD44 IM7 FC
APC/Cyanine7 anti-mouse/human CD44 IM7 FC
PerCP/Cyanine5.5 anti-mouse/human CD44 IM7 FC
PerCP anti-mouse/human CD44 IM7 FC
Brilliant Violet 421™ anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Brilliant Violet 570™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 785™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 510™ anti-mouse/human CD44 IM7 FC
Ultra-LEAF™ Purified anti-mouse/human CD44 IM7 FC,CyTOF®,ELISA,IHC,IP,CMCD,Stim
Brilliant Violet 650™ anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 (Maxpar® Ready) IM7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD44 IM7 ICC,FC,IHC-P,SB
PE/Dazzle™ 594 anti-mouse/human CD44 IM7 FC
Brilliant Violet 711™ anti-mouse/human CD44 IM7 FC
APC/Fire™ 750 anti-mouse/human CD44 IM7 FC
TotalSeq™-A0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-C0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-B0073 anti-mouse/human CD44 IM7 PG
Spark YG™ 570 anti-mouse/human CD44 IM7 FC,IHC-P
Spark YG™ 593 anti-mouse/human CD44 IM7 FC
TotalSeq™-D0073 anti-mouse/human CD44 IM7 PG
Brilliant Violet 750™ anti-mouse/human CD44 IM7 FC
PerCP/Fire™ 806 anti-mouse/human CD44 IM7 FC
Spark Red™ 718 anti-mouse/human CD44 IM7 FC
PE/Fire™ 810 anti-mouse/human CD44 IM7 FC
Spark Blue™ 550 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark Red™ 718 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Go To Top Version: 4    Revision Date: 10/15/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account